{
  "id": 751,
  "text": "Lancet，1997，350（9077）：535-540.DOI：10.1016/S0140-6736（97）02250-2.［4］SEDLIS A，BUNDY B N，ROTMAN M Z，et al.A randomizedtrial of pelvic radiation therapy versus no further therapy in selectedpatients with stage Ⅰ B carcinoma of the cervix after radicalhysterectomy and pelvic lymphadenectomy：a Gynecologic OncologyGroup Study［J］.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Lancet，1997，350（9077）：535-540.DOI：10.1016/S0140-6736（97）02250-2.［4］SEDLIS A，BUNDY B N，ROTMAN M Z，et al.A randomizedtrial of pelvic radiation therapy versus no further therapy in selectedpatients with stage Ⅰ B carcinoma of the cervix after radicalhysterectomy and pelvic lymphadenectomy：a Gynecologic OncologyGroup Study［J］.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于已经进行了根治性子宫切除术和盆腔淋巴切除术的ⅠB期宫颈癌患者是否需要额外进行盆腔放射治疗的问题，现有研究表明，选择性盆腔放射治疗可能对这类患者具有积极作用。是否需要额外的放射治疗常取决于具体的病理特征和风险因素，包括肿瘤大小、淋巴结受累情况、脉管侵犯等。临床试验数据显示，对于某些具有高风险病理特征的患者，额外的盆腔放射治疗在降低复发风险方面具有显著效果。因此，建议医生根据患者的具体病况和病理报告，考虑盆腔放射治疗作为一种辅助治疗手段，以优化治疗结果。",
  "query": "在宫颈癌的治疗过程中，对于已经进行了根治性子宫切除术和盆腔淋巴切除术的ⅠB期患者，是否需要额外进行盆腔放射治疗？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在宫颈癌的治疗过程中，对于已经进行了根治性子宫切除术和盆腔淋巴切除术的ⅠB期患者，是否需要额外进行盆腔放射治疗？\n\n<reference text>: Lancet，1997，350（9077）：535-540.DOI：10.1016/S0140-6736（97）02250-2.［4］SEDLIS A，BUNDY B N，ROTMAN M Z，et al.A randomizedtrial of pelvic radiation therapy versus no further therapy in selectedpatients with stage Ⅰ B carcinoma of the cervix after radicalhysterectomy and pelvic lymphadenectomy：a Gynecologic OncologyGroup Study［J］.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于已经进行了根治性子宫切除术和盆腔淋巴切除术的ⅠB期宫颈癌患者是否需要额外进行盆腔放射治疗的问题，现有研究表明，选择性盆腔放射治疗可能对这类患者具有积极作用。是否需要额外的放射治疗常取决于具体的病理特征和风险因素，包括肿瘤大小、淋巴结受累情况、脉管侵犯等。临床试验数据显示，对于某些具有高风险病理特征的患者，额外的盆腔放射治疗在降低复发风险方面具有显著效果。因此，建议医生根据患者的具体病况和病理报告，考虑盆腔放射治疗作为一种辅助治疗手段，以优化治疗结果。"
}